Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Development of a tapping device: a new needle insertion method for prostate brachytherapy.

V Lagerburg1, M A Moerland, M K Konings

  • 1Department of Radiotherapy, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. v.lagerburg@azu.nl

Physics in Medicine and Biology
|February 10, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Feasibility and safety of single-fraction sub-ablative radiotherapy with systemic therapy in colorectal cancer patients with ≤ 10 metastases: A multicenter pilot study (NCT05375708).

Clinical and translational radiation oncology·2025
Same author

Accuracy of intertrochanteric osteotomy for patients with slipped capital femoral epiphysis operated with 3D printed patient-specific guides.

Journal of orthopaedic surgery and research·2024
Same author

3D printed patient-specific fixation plates for the treatment of slipped capital femoral epiphysis: Topology optimization vs. conventional design.

Journal of the mechanical behavior of biomedical materials·2023
Same author

Design considerations for patient-specific bone fixation plates: a literature review.

Medical & biological engineering & computing·2023
Same author

[Experiences with MRI-guided brachytherapy for radiorecurrent prostate cancer].

Nederlands tijdschrift voor geneeskunde·2022
Same author

Clinical implementation and feasibility of long-course fractionated MR-guided chemoradiotherapy for patients with esophageal cancer: An R-IDEAL stage 1b/2a evaluation of technical innovation.

Clinical and translational radiation oncology·2022

A new tapping device for prostate brachytherapy needle insertion was developed. This device minimizes prostate motion and deformation by delivering controlled momentum, showing promising results in preliminary tests.

Area of Science:

  • Medical Devices
  • Surgical Technology
  • Biomedical Engineering

Background:

  • Current needle insertion methods for prostate brachytherapy involve pushing, which can cause unwanted prostate motion and deformation.
  • Minimizing intra-procedural motion is crucial for accurate radiation delivery in brachytherapy.

Purpose of the Study:

  • To develop and evaluate a novel pneumatic tapping device for controlled needle insertion in prostate brachytherapy.
  • To investigate the relationship between applied air pressure and delivered momentum by the tapping device.
  • To assess the device's efficacy in reducing prostate motion and deformation during needle insertion.

Main Methods:

  • A pneumatically driven tapping device was designed to deliver a specific momentum to the needle.
  • Manual tapping momentum was measured to establish a baseline (0.50 +/- 0.07 N s).

Related Experiment Videos

  • The device's performance was tested on a beef model simulating prostate tissue, placed on a mobile platform to measure displacement and rotation.
  • Main Results:

    • Delivered momentum from the tapping device increased linearly with applied air pressure.
    • Testing on a beef model showed minimal displacement (2 mm) and rotation (6 degrees) at the highest pressure (4 bar).
    • A significant correlation was observed between applied pressure and reduced motion, indicating effective control.

    Conclusions:

    • The developed tapping device offers a controlled method for needle insertion in prostate brachytherapy.
    • The pneumatic system allows for precise momentum delivery, potentially reducing prostate motion and deformation.
    • Further studies are warranted to validate the device's clinical efficacy and impact on treatment outcomes.